Lantheus Appoints Vivian Yao as Chief Human Resources

NORTH BILLERICA, Massachusetts, Dec. 1, 2021 (GLOBE NEWSWIRE) – Lantheus Holdings, Inc. (“The Company”) (NASDAQ: LNTH), a leading company and fully integrated provider committed to innovative imaging diagnostics, targeted therapies, and artificial intelligence solutions to find, control and track critical medical conditions, has announced the appointment of Vivian Yao to its executive team as Chief Human Resources at Lanthus. Ms. Yao will report directly to Lantheus’ President and CEO, Mary Ann Hino. In this role, Ms. Yao will oversee all aspects of Lantheus’ experience for employees and the workplace, including ensuring best-in-class talent operations, people operations, overall rewards, organization effectiveness, and next-generation HR capability.

“We are very excited to have Vivian join our team as we continue to grow our company,” said Mary Ann Heno, President and CEO of Lantheus. “At Lantheus, we know that our greatest asset is our people, and the resilience of the current environment gives us an opportunity to reimagine what we can achieve together. With Vivian’s strong experience developing and fostering a culture of innovation across many complex global companies, I am confident in her ability to lead us in Live our values ​​and motivate our employees to strive to be their best, so that we can continue to exceed expectations for clients and patients alike.”

“It is a great honor to join Lantheus, an organization that has taken upon itself an important purpose of finding, controlling and following up on serious medical conditions,” said Ms. Yao. “I look forward to working alongside the Lantheus management team and our employees to develop and implement an effective long-term foundation to attract new talent and support the continued growth and development of our employees.”

Ms. Yao has over 25 years of experience in the field of human resources. Ms. Yao most recently held the position of Vice President of Human Resources for the EMS division of Jubail, where she was responsible for more than 100,000 employees globally. Prior to Jubail, she held HR executive positions of increasing responsibility at Johnson & Johnson for Ethicon, Global Surgery, Global Medical Devices, and One J&J China over the course of five years. Additionally, Ms. Yao has spent 11 years at GE in various global HR roles increasing responsibilities. She holds a Bachelor’s degree in International Business from the China Foreign Affairs College and an MBA from the University of Michigan.

About Lantheus Holdings, Inc.
Lantheus Holdings, Inc. It is the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB, a leading company and fully integrated provider committed to innovative imaging diagnostics, targeted therapies, and AI solutions to find the fight and follow.® Serious medical conditions. Lantheus provides a wide range of products, including DEFINITY Echocardiography Agent® injectable suspension vial (Perflutren Lipid Microsphere); PYLARIFY®PSMA PET imaging agent for the detection of suspected recurrent or metastatic prostate cancer; TechneLite® (Technetium generator Tc99m), a technetium-based generator that provides essential medical isotopes used in nuclear medicine procedures; AZEDRA® For the treatment of some rare neuroendocrine tumors. and RELISTOR® For the treatment of opioid-induced constipation, a partnership with Bausch Health Companies, Inc. The company is headquartered in North Billerica, Massachusetts with offices in New Jersey, Canada and Sweden. For more information visit www.lantheus.com.

Safe harbor for forward-looking and cautionary statements
This press release contains “forward-looking statements” as defined under US federal securities laws. Forward-looking statements may be identified by their use of terms such as build, ability, confidence, continuity, development, implementation, growth, aspiration, will, and other similar terms. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those shown in the forward-looking statements. Readers are cautioned not to place undue reliance on the forward-looking statements contained in this document, which speak only as of the date of this document. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. The risks and uncertainties that could cause our actual results to differ materially from those described in the forward-looking statements are discussed in our filings with the Securities and Exchange Commission (including those described in the Risk Factors section of our annual reports on Form 10-K and our quarterly reports on Form 10). -Q).

Contacts:
Mark Kinarni
Senior Manager, Investor Relations
978-671-8842
ir@lantheus.com

Melissa Downs
Corporate Communications Manager
646-975-2533
media@lantheus.com

social networks:
Website: https://www.lantheus.com/
LinkedIn: https://www.linkedin.com/company/lantheus/

An accompanying image is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/734c73ba-5852-4ca4-b364-3a38d2b908fd

.

Leave a reply:

Your email address will not be published.